Phibro Animal Health Corporation revised earnings guidance for the fiscal year ending June 30, 2023. For the year, the company expects net sales of $960 million - $1 billion (unchanged); net income of $34 million- $38 million, from $39 million- $43 million; diluted EPS of $0.84 - $0.94, from $0.96 - $1.06.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.98 USD | -1.48% | +1.58% | +55.27% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.27% | 728M | |
-11.98% | 79.26B | |
+25.75% | 3.74B | |
0.00% | 3.27B | |
+17.06% | 1.69B | |
-6.22% | 1.56B | |
-23.36% | 1.29B | |
-3.03% | 1.28B | |
-12.76% | 1.14B | |
+0.79% | 1.06B |
- Stock Market
- Equities
- PAHC Stock
- News Phibro Animal Health Corporation
- Phibro Animal Health Corporation Revises Earnings Guidance for the Fiscal Year Ending June 30, 2023